Drug-induced and toxic myopathies
- 31 December 2003
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Rheumatology
- Vol. 17 (6), 877-907
- https://doi.org/10.1016/j.berh.2003.11.002
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Treating dyslipidemia with statins: The risk-benefit profileAmerican Heart Journal, 2003
- Cytochrome P450 Drug Interactions Within the HMG-CoA Reductase Inhibitor ClassDrug Safety, 2003
- Zoledronic AcidDrugs, 2003
- Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleDrug Safety, 2002
- Drug Target PharmacogenomicsAmerican Journal of PharmacoGenomics, 2001
- PamidronateDrugs & Aging, 1998
- Severe Rattlesnake Envenomation With Anaphylaxis and RhabdomyolysisAnnals of Emergency Medicine, 1995
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyThe New England Journal of Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanThe New England Journal of Medicine, 1990
- Hyperthermia and Rhabdomyolysis in Self‐Poisoning with Paracetamol and SalicylatesActa Medica Scandinavica, 1979